Although STK11 is inactivated by a large spectrum of truncating mutation and behave as a tumor suppressor gene in different tumor models through mTOR inhibition [9–11], recent studies suggest that STK11 may also gain oncogenic properties. This evidence concerns the gene MTOR and neoplasm.